Cargando…
Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer
Vascular endothelial growth factor receptor 2 (VEGFR2) is highly expressed in tumor‐associated endothelial cells, where it modulates tumor‐promoting angiogenesis, and it is also found on the surface of tumor cells. Currently, there are no Ab therapeutics targeting VEGFR2 approved for the treatment o...
Autores principales: | Lu, Ruei‐Min, Chiu, Chiung‐Yi, Liu, I‐Ju, Chang, Yu‐Ling, Liu, Yaw‐Jen, Wu, Han‐Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890446/ https://www.ncbi.nlm.nih.gov/pubmed/31578782 http://dx.doi.org/10.1111/cas.14208 |
Ejemplares similares
-
Neutralizing mAbs against SFTS Virus Gn Protein Show Strong Therapeutic Effects in an SFTS Animal Model
por: Shimojima, Masayuki, et al.
Publicado: (2022) -
AB009. The development of photoselective vaporization of the prostate
por: Liu, Yili
Publicado: (2017) -
The therapeutic efficacy of I(131)-PSCA-mAb in orthotopic mouse models of prostate cancer
por: Yu, Shengqiang, et al.
Publicado: (2013) -
Development of therapeutic antibodies for the treatment of diseases
por: Lu, Ruei-Min, et al.
Publicado: (2020) -
AB050. Nursing managements of acupuncturing biopsy of prostate
por: Liu, Yu-Ying
Publicado: (2018)